Most Recent
Billionaire Clive Palmer cannot defend the truth of alleged defamatory imputations that Western Australia Premier Mark McGowan tried to "cover up" criminal acts and was "corrupt", the premier's barrister has told the court.
The daughter of NRL great Mark Geyer has been awarded $125,000 in a defamation case against the owner of an NRL Memes page over a post wrongfully claiming she was involved in the Tyrone May sex scandal.
Three media companies have been granted special leave by the High Court to challenge a finding that they could be held liable for allegedly defamatory remarks left under news articles they posted on Facebook.
The columnist behind two allegedly defamatory Australian Financial Review articles has told the court that he believed former Blue Sky managing director Dr Elaine Stead was "cretinously stupid" because of her "astonishingly ridiculous" behavior on social media at the time of the company's collapse.
Nine-owned Fairfax has denied that two Australian Financial Review articles implied that venture capitalist Dr Elaine Stead "deliberately" destroyed capital, as it seeks to significantly reduce the defamation case it faces.
Being called a fraud is not as bad as being labelled a "terrible investor", venture capitalist Dr Elaine Stead has said during trial in her high-profile defamation case against the Nine-owned Fairfax over two articles about her involvement in the failed investment company Blue Sky.
Venture capitalist Dr Elaine Stead has taken the stand in a high-profile defamation case against the Nine-owned Fairfax, saying that she felt "shame, embarrassment, humiliation and guilt" over two allegedly defamatory Australian Financial Review articles about her role in the collapsed investment firm Blue Sky.
Former Blue Sky Capital venture capitalist Dr Elaine Stead is seeking over $671,000 in damages from the publisher of the Australian Financial Review over two articles she describes as a "misogynist attack" and "vitriolic abuse" that did significant damage to her professional reputation.
Two psychiatrists at the heart of the Chelmsford deep sleep therapy scandal have had their defamation cases against publisher HarperCollins dismissed ,with a judge finding the lawsuits were an attempt to "rewrite history" regarding harm done to patients receiving their controversial treatment.
The CEO of fintech company iSignthis turned down an offer by the Australian Financial Review to pay $30,000 and retract portions of an article he claimed falsely linked him to a money laundering scheme, but his defamation case against publisher Fairfax might not proceed to trial if the judge overseeing the case can help it.